Clinical trial · Observational
Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve
Pelvic Sentinel Node According to SHREC-trial for the Application of the 2021 European Recommendations for Lymph Node Staging Strategy in Endometrial Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
According to ESGO-ESTRO-ESMO guidelines, pelvic Sentinel lymph node detection is suitable for lymph node staging in endometrial carcinoma of the uteri. Nonetheless, a learning curve is mandatory to ensure the surgical quality of the sampling. The aim of the study is to assess the success of sentinel lymph node detection according to SHREC-Trial surgical strategy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Bilateral node detection rates
- timeFrame
- Day 0 (during surgery)
- description
- target = 70% to 90%
Secondary outcomes (4)
- measure
- sentinel nodes
- timeFrame
- Day 0 (during surgery)
- description
- number of sentinel nodes collected
- measure
- Salvage operations in case of GS failure
- timeFrame
- Day 0 (during surgery)
- description
- Number of salvage operations
- measure
- adverse events
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Letter of non objection Endometrial carcinoma Stage FIGO I-II whatever the histological subtype. ESGO-ESMO-ESTRO 2021 risk classification : low, intermediate, high intermediate, high Laparoscopic approach. Exclusion Criteria: Participation refusal Medical contraindication to laparoscopic approach. Stage FIGO \> II Suspected Indocyanine Green allergy
References
Publications (0)
Data not yet available